Immunoinformatic approach to the design of a novel multi-epitope vaccine against Leishmania major fused to human IgG-Fc

These findings provide novel insights for developing effective candidates for cutaneous leishmaniasis vaccines. However, laboratory experiments are necessary to evaluate its protective effects.

Authors

Institutions

Publication Details

Journal
Research in Pharmaceutical Sciences
Published
2024-11-01
DOI
https://doi.org/10.4103/rps.rps_145_24
Citations
2
Primary Topic
vaccines and immunoinformatics approaches
Type
article
Field-Weighted Citation Impact
0.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunoinformatic approach to the design of a novel multi-epitope vaccine against Leishmania major fused to human IgG-Fc

Mahmood Fadaie, Zabihollah Shahmoradi, Hossein Khanahmad
2 citations
Research in Pharmaceutical Sciences
vaccines and immunoinformatics approaches
0.47
article

Immunoinformatic approach to the design of a novel multi-epitope vaccine against Leishmania major fused to human IgG-Fc

Mahmood Fadaie, Zabihollah Shahmoradi, Hossein Khanahmad
article en
2 citations

Abstract

These findings provide novel insights for developing effective candidates for cutaneous leishmaniasis vaccines. However, laboratory experiments are necessary to evaluate its protective effects.

Research in Pharmaceutical SciencesVol. 19(6)
Isfahan University of Medical Sciences (IR)
Isfahan University of Medical Sciences
Openalex Percentile: Top 33%
vaccines and immunoinformatics approaches
0.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.